Core Insights - Synopsys reported stronger-than-expected fourth-quarter results and provided an optimistic earnings forecast for fiscal 2026, driven by increased demand for semiconductor design software supporting AI architectures [1] Financial Performance - Fourth-quarter adjusted earnings were $2.90 per share, surpassing expectations of $2.78, while revenue reached $2.26 billion, slightly above the forecast of $2.25 billion [2] - Revenue increased by 37.8% year-over-year, with Ansys contributing $667.7 million to the total [2] - For fiscal 2025, Synopsys achieved a record revenue of $7.05 billion, reflecting a growth of approximately 15%, and ended the year with a backlog of $11.4 billion [2] Future Guidance - For fiscal 2026, Synopsys guided earnings of $14.32 to $14.40 per share, exceeding the consensus estimate of $14.05 [3] - The company anticipates revenue between $9.56 billion and $9.66 billion, with approximately $2.9 billion expected from Ansys [3] - For the fiscal first quarter, Synopsys projected adjusted earnings of $3.52 to $3.58 per share and revenue of $2.36 billion to $2.42 billion, both above analyst expectations [3]

Core Insights - Analysts express a positive outlook despite a slight decline in shares, with J.P. Morgan suggesting the company may be conservative in its full-year 2026 guidance, projecting $9.6 billion after finishing FY 25 at $7 billion [1] Group 1: Financial Performance and Guidance - The company has a significant backlog entering FY 26, amounting to $11.5 billion, driven by strength across its portfolio [3] - The FY 26 guidance assumes a challenging environment in China, with a 20% decline in business due to headwinds, and the company has de-risked this from its forecast [7] Group 2: Market Trends and Opportunities - There is a notable shift among hyperscalers towards multiple alternatives for building and optimizing their technology stacks, including purchasing merchant chips and developing custom solutions [4] - The company sees opportunities in providing essential mass for silicon design and system integration, particularly following a $2 billion investment endorsement from NVIDIA [5][6] Group 3: Strategic Partnerships and Investments - NVIDIA's investment is viewed as a significant endorsement of the company's strategy to deliver engineering solutions from silicon to systems, emphasizing the importance of physical simulation in product development [6] - Jensen from NVIDIA highlights the potential for mutual financial gain and alignment of roadmaps to accelerate investments [8]

Core Points - The Gross Law Firm has issued a notice to shareholders of Synopsys, Inc. regarding a class action lawsuit related to misleading statements made by the company during a specified class period [1] - The class period for the allegations spans from December 4, 2024, to September 9, 2025, during which the company is accused of failing to disclose critical information affecting its financial performance [2] - Shareholders are encouraged to register for the class action by December 30, 2025, to potentially become lead plaintiffs and receive updates on the case [3] Allegations Summary - The complaint alleges that Synopsys' increased focus on artificial intelligence customers negatively impacted the economics of its Design IP business [2] - It is claimed that certain strategic decisions were unlikely to achieve their intended results, leading to a material negative impact on financial outcomes [2] - The allegations suggest that the company's positive statements regarding its business and prospects were misleading and lacked a reasonable basis [2] Next Steps for Shareholders - Shareholders who purchased shares during the class period should register to be enrolled in a portfolio monitoring system for case updates [3] - The deadline for seeking lead plaintiff status is December 30, 2025, with no cost or obligation to participate in the case [3] Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4] - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock value [4]

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Core Insights - Synopsys, Inc. reported stronger-than-expected fourth-quarter results with adjusted earnings of $2.90 per share and revenue of $2.26 billion, slightly above analyst estimates [2] - For fiscal 2026, Synopsys projects adjusted EPS between $14.32 and $14.40 and revenue between $9.56 billion and $9.66 billion, exceeding consensus expectations [2] Analyst Ratings and Forecasts - BofA Securities upgraded Synopsys from Neutral to Buy, raising the price target from $500 to $560 [3] - Rosenblatt maintained a Buy rating with a price target of $560 [3] - JPMorgan reiterated an Overweight rating and increased the price target from $600 to $650 [3] Analyst Commentary - BofA's analyst sees Synopsys as a lower-beta way to gain AI exposure in 2026, noting reduced risk around China and Intel revenue, and strong momentum from Ansys [4] - Rosenblatt's analyst highlighted that fourth-quarter revenue was slightly above expectations, driven by a full quarter contribution from Ansys, which grew about 10% year-over-year [7] - JPMorgan's analyst noted that fiscal 2026 is a "transition year" with guidance implying high-single-digit growth for core EDA and low- to mid-single-digit growth for Design IP [9] Revenue and EPS Projections - Analysts project first-quarter revenue of $2.39 billion and adjusted EPS of $3.55 [6][8][10] - Fiscal revenue expectations are $9.61 billion with adjusted EPS of $14.37 according to BofA, while Rosenblatt expects $9.64 billion and $14.35, and JPMorgan anticipates $9.65 billion and $14.39 [6][8][10] Market Performance - Synopsys stock traded lower by 0.59% at $473.03 at the time of publication [10]

Synopsys, Inc. (NASDAQ:SNPS) posted better-than-expected earnings for the fourth quarter on Wednesday.Synopsys reported quarterly earnings of $2.90 per share, which beat the Street of $2.78. Quarterly revenue came in at $2.26 billion, which beat the analyst estimate of $2.25 billion."The Synopsys team delivered a solid finish to a year that redefined our company as the leader in engineering solutions from silicon to systems," said Sassine Ghazi, CEO of Synopsys.Synopsys sees fiscal 2026 adjusted EPS of $14. ...

Group 1 - Synopsys, Inc. reported fourth-quarter earnings of $2.90 per share, exceeding the analyst expectation of $2.78, with quarterly revenue of $2.26 billion, surpassing the estimate of $2.25 billion [1] - CEO Sassine Ghazi highlighted the company's strong performance, stating it redefined Synopsys as a leader in engineering solutions from silicon to systems [1] Group 2 - For fiscal 2026, Synopsys projects adjusted EPS between $14.32 and $14.40, significantly above the analyst estimate of $12.85, and revenue expectations of $9.56 billion to $9.66 billion, compared to the $7.04 billion estimate [2] - Following the earnings announcement, Synopsys shares fell by 0.8% to $472.13 [2] Group 3 - Piper Sandler analyst Clarke Jeffries maintained an Overweight rating on Synopsys but lowered the price target from $630 to $602 [3] - Needham analyst Charles Shi maintained a Buy rating and raised the price target from $550 to $580 [3] - B of A Securities analyst Vivek Arya upgraded Synopsys from Neutral to Buy, increasing the price target from $500 to $560 [3] - Keybanc analyst Jason Celino maintained an Overweight rating and raised the price target from $575 to $600 [3] - Wells Fargo analyst Joe Quatrochi maintained an Equal-Weight rating and increased the price target from $445 to $500 [3]

智通财经APP获悉，周四，电子设计自动化与IP供应商新思科技(SNPS.US)公布的第四财季业绩及2026 财年展望显示业务趋于稳定，获得多家华尔街机构积极评价及上调目标价。 富国银行则维持"中性"评级，但仍将目标价从445美元上调至500美元。分析师Joe Quatrochi与Travis Poulin认为，公司对2026财年的初步指引"喜忧参半"，Ansys收入预计29亿美元，高于其预期，但意味着 EDA增长可能低于此前设想。他们估计2026财年核心EDA增长为7%至8%，低于此前预测的8.5%，也低 于市场约10%的预期。同时，IP收入仍将维持疲弱。富国银行表示将继续关注公司关键增长驱动，包括 Ansys协同解决方案、Agentic AI发展，以及中国业务基数效应改善为整体增长带来的潜在提速。 Needham亦维持"买入"评级，将目标价从550美元上调至580美元。分析师Charles Shi与Denis Pyatchanin 指出，公司对2026财年第一季度的指引略低于市场预期，但对于财年末发布业绩的公司来说，"来年的 指引才是投资者关注的核心"。他们认为市场先前预期公司在完成大型并购后会给出较为艰难 ...

Core Viewpoint - The report summarizes significant rating changes from various investment firms that are expected to impact the market. Upgraded Ratings - Jefferies upgraded Roku (ROKU) from "Hold" to "Buy," raising the target price from $100 to $135, anticipating over 20% growth in platform revenue under optimistic scenarios [5] - Piper Sandler upgraded Unity (U) from "Neutral" to "Outperform," increasing the target price from $43 to $59, citing a favorable outlook for the mobile app advertising market entering 2026 [5] - Citigroup upgraded Thermo Fisher Scientific (TMO) from "Neutral" to "Buy," raising the target price from $580 to $660, expecting benefits from increased pharmaceutical spending and local industry advantages [5] - Bank of America upgraded Synopsys (SNPS) from "Neutral" to "Buy," increasing the target price from $500 to $560, noting reduced risks in sales to China and Intel, and potential for attractive rebound [5] - Bank of America upgraded Visa (V) from "Neutral" to "Buy," setting a target price of $382, indicating attractive return potential after recent underperformance [5] Downgraded Ratings - Bank of America downgraded PayPal (PYPL) from "Buy" to "Neutral," lowering the target price from $93 to $68, citing delays in revitalizing core payment business growth [5] - Harbor Research downgraded General Electric Energy (GEV) from "Buy" to "Neutral," without providing a target price, stating current valuation is reasonable [5] - Bank of America downgraded Alcon (ALC) from "Buy" to "Underperform," reducing the target price from $100 to $75, due to limited upside and market uncertainties [5] - Deutsche Bank downgraded Norfolk Southern Railway (NSC) from "Buy" to "Hold," setting a target price of $297, attributing the downgrade to unresolved merger issues with Union Pacific Railway (UNP) [5] - Deutsche Bank downgraded Union Pacific Railway from "Buy" to "Hold," setting a target price of $245, despite strong performance over two quarters, citing poor stock performance [5] Initiated Coverage - Freedom Capital initiated coverage on Shift4 Payments (FOUR) with a "Buy" rating and a target price of $80, viewing recent pullbacks as an attractive entry point [5] - Bernstein initiated coverage on BridgeBio Pharma (BBIO) with an "Outperform" rating and a target price of $94, suggesting that short-term expectations are reasonable but long-term may be overly optimistic [5] - B. Riley initiated coverage on Chime Bank (CHYM) with a "Buy" rating and a target price of $35, indicating a 40% potential upside, highlighting its profitable and high-growth digital banking services [5] - Morgan Stanley initiated coverage on Elbit Systems (ESLT) with a "Hold" rating and a target price of $531, noting that most growth potential is already reflected in the current stock price after a 95% increase this year [5] - Goldman Sachs initiated coverage on Abercrombie & Fitch (ANF) with a "Buy" rating and a target price of $120, favoring companies with store expansion capabilities and pricing power in the apparel retail sector [5]

Synopsis - Synopsis reported adjusted EPS of 290, beating the expected 278, with revenue of 2.4 billion, slightly above the anticipated 2.24 billion [2][4] - The company achieved record full-year performance with fiscal 2025 revenue reaching 7.1 billion, a 15% increase from fiscal 2024 [4] - The backlog stood at 11.4 billion, and the CFO anticipates another revenue record in 2026 [4] - The ANCIS acquisition contributed 2.9 billion in revenue, impacting Q4 results [5] - Analysts are optimistic, with Morgan Stanley raising its price target to 550 from 510, Bank of America upgrading to a buy with a target of 560, and JP Morgan Chase increasing its target to 650 [6][7] Alphabet (Google) - Alphabet has been a strong performer in the MAG 7, with Piper Sandler reiterating an overweight rating and raising the price target from 330 to 365 [8][9] - The increase reflects stronger fundamentals and improved ad buyer sentiment, with Google search gaining digital ad budget share for the first time in three years [9][10] - The latest iteration of Gemini is performing well, and both Performance Max and Gemini are driving incremental revenue and enhancing advertiser insights [11][12] Eli Lilly - Eli Lilly reported positive trial results for its next-generation weight loss drug, showing patients lost about 25% of their weight over 68 weeks [14][15] - The drug targets conditions linked to obesity, reinforcing Eli Lilly's position in a market projected to reach 100 billion by 2030 [15] - Eli Lilly has been outperforming competitors like Novartis in the obesity treatment sector [16]